Erratum to: 2016 updated MASCC/ESMO consensus recommendations: Prevention of nausea and vomiting following moderately emetogenic chemotherapy.

Roila, Fausto; Warr, David; Hesketh, Paul J; Gralla, Richard; Herrstedt, Jorn; Jordan, Karin; Aapro, Matti; Ballatori, Enzo; Rapoport, Bernardo

Roila, Fausto; Warr, David; Hesketh, Paul J; Gralla, Richard; Herrstedt, Jorn; Jordan, Karin; Aapro, Matti; Ballatori, Enzo; Rapoport, Bernardo.

Afiliación

Roila F; Medical Oncology, Santa Maria Hospital, Via Tristano di Joannuccio 1, 05100, Terni, Italy. roila.fausto@libero.it.
Warr D; Cancer Clinical Research Unit, Princess Margaret Cancer Centre, Toronto, Canada.
Hesketh PJ; Lahey Health Cancer Institute, Burlington, USA.
Gralla R; Albert Einstein College of Medicine, Jacobi Medical Center, New York, NY, USA.
Herrstedt J; Department of Oncology, Odense University, 5000, Odense, Denmark.
Jordan K; Department of Hematology/Oncology, Martin Luther University, Halle-Wittenberg, Halle, Germany.
Aapro M; Clinique de Genolier, Multidisciplinary Oncology Institute, Genolier, Switzerland.
Ballatori E; , Spinetoli, Italy.
Rapoport B; Medical Oncology Centre of Rosebank, 129 Oxford Road, Johannesburg, South Africa.

Support Care Cancer ; 25(1): 295-296, 2017 01.

Article en En | MEDLINE | ID: mdl-27624467

Buscar en Google

Imprimir

XML

PubMed Links

Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Support Care Cancer Asunto de la revista: NEOPLASIAS / SERVICOS DE SAUDE Año: 2017 Tipo del documento: Article País de afiliación: Italia

Buscar en Google

Imprimir

XML

PubMed Links